| Title | Ketorolac tromethamine 0.4% as a treatment for allergic conjuctivitis. | | Author(s) | Schechter BA | | Institution | Florida Eye Microsurgical Institute, 1717 W Woolbright Road, Boynton Beach, FL 33426, USA +1 561 737 5500 ; +1 561 737 7055 ; BDSCH77@aol.com. | | Source | Expert Opin Drug Metab Toxicol 2008 Apr; 4(4):507-11. | | Abstract | Background: Acular LS (ketorolac tromethamine 0.4%) ophthalmic solution, a reformulation of the original Acular (ketorolac tromethamine 0.5%), is indicated for the reduction of ocular pain and burning/stinging following corneal refractive surgery.
Objective: This manuscript will review the off-label application of this topical NSAID medication as a treatment for allergic conjunctivitis.
Methods: An extensive MedLine search was undertaken to evaluate data on the use of ketorolac for allergic conjunctivitis. Data on both human and animal data were reviewed. Results/conclusions: Studies have demonstrated that ketorolac 0.4% has equivalent efficacy to ketorolac 0.5%. Several studies have demonstrated that ketorolac effectively treats allergic conjunctivitis. Ketorolac 0.4% is effective when used as either monotherapy or as adjunct therapy to steroids. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 18433352 |
|
